BioMed X launches Harvard pilot to connect academia and pharma
Projects selected for advancement will move forward through the Harvard Office of Technology Development’s processes for sponsored research agreements
Projects selected for advancement will move forward through the Harvard Office of Technology Development’s processes for sponsored research agreements
The primary goal of the collaboration is joint research into trending and next-generation molecules
Growing patent filings and tier-2 innovators reflect expanding national research base
The discussion at the fourth session was centered on the fusion of academic rigor and industrial pragmatism as a key to pioneering solutions for sustainable and prosperous future
The next phase of growth in pharma depends on the industry-oriented workforce, risk investment, academic revamp, and creation of R&D hubs, say experts .
India should explore Sustainability-Linked Incentives (SLI) targeting innovations in the 12 principles of green chemistry
India’s pharmaceutical sector stands at a pivotal inflection point
Leaders from science, policy, industry, and investment came together in New Delhi to examine how alignment across the biotechnology value chain can turn innovation into outcomes at scale
Subscribe To Our Newsletter & Stay Updated